Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Variability in German Cockroach Extract Composition Greatly Impacts T Cell Potency in Cockroach-Allergic Donors.

Birrueta G, Frazier A, Pomés A, Glesner J, Filep S, Schal C, Jeong KY, McMurtrey C, Vander Schans T, Hildebrand WH, Busse P, Beigelman A, Bacharier LB, Peters B, Sette A, Schulten V.

Front Immunol. 2019 Feb 27;10:313. doi: 10.3389/fimmu.2019.00313. eCollection 2019.

2.

MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage.

Harriff MJ, McMurtrey C, Froyd CA, Jin H, Cansler M, Null M, Worley A, Meermeier EW, Swarbrick G, Nilsen A, Lewinsohn DA, Hildebrand W, Adams EJ, Lewinsohn DM.

Sci Immunol. 2018 Jul 13;3(25). pii: eaao2556. doi: 10.1126/sciimmunol.aao2556.

PMID:
30006464
3.

Role of MAIT cells in pulmonary bacterial infection.

Hartmann N, Harriff MJ, McMurtrey CP, Hildebrand WH, Lewinsohn DM, Kronenberg M.

Mol Immunol. 2018 Sep;101:155-159. doi: 10.1016/j.molimm.2018.06.270. Epub 2018 Jun 26. Review.

PMID:
29940408
4.

Urinary Peptides As a Novel Source of T Cell Allergen Epitopes.

da Silva Antunes R, Pham J, McMurtrey C, Hildebrand WH, Phillips E, Mallal S, Sidney J, Busse P, Peters B, Schulten V, Sette A.

Front Immunol. 2018 Apr 26;9:886. doi: 10.3389/fimmu.2018.00886. eCollection 2018.

5.

NetH2pan: A Computational Tool to Guide MHC Peptide Prediction on Murine Tumors.

DeVette CI, Andreatta M, Bardet W, Cate SJ, Jurtz VI, Jackson KW, Welm AL, Nielsen M, Hildebrand WH.

Cancer Immunol Res. 2018 Jun;6(6):636-644. doi: 10.1158/2326-6066.CIR-17-0298. Epub 2018 Apr 3.

6.

Development of novel monoclonal antibodies to dog leukocyte antigen DR displaying direct and immune-mediated cytotoxicity toward canine lymphoma cell lines.

Lisowska M, Pawlak A, Kutkowska J, Hildebrand W, Ugorski M, Rapak A, Miazek A.

Hematol Oncol. 2018 Mar 24. doi: 10.1002/hon.2507. [Epub ahead of print]

PMID:
29573261
7.

Riboflavin Metabolism Variation among Clinical Isolates of Streptococcus pneumoniae Results in Differential Activation of Mucosal-associated Invariant T Cells.

Hartmann N, McMurtrey C, Sorensen ML, Huber ME, Kurapova R, Coleman FT, Mizgerd JP, Hildebrand W, Kronenberg M, Lewinsohn DM, Harriff MJ.

Am J Respir Cell Mol Biol. 2018 Jun;58(6):767-776. doi: 10.1165/rcmb.2017-0290OC.

8.

Response to the comments on "Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins".

Daga S, Moyse H, Briggs D, Lowe D, Evans N, Jones J, Buchli R, McMurtrey C, Mulder A, Hildebrand W, Claas F, Higgins R, Mitchell DA, Zehnder D.

Hum Immunol. 2018 Feb;79(2):130-131. doi: 10.1016/j.humimm.2017.12.001. Epub 2017 Dec 5. No abstract available.

PMID:
29217367
9.

T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells.

McMurtrey C, Harriff MJ, Swarbrick GM, Duncan A, Cansler M, Null M, Bardet W, Jackson KW, Lewinsohn DA, Hildebrand W, Lewinsohn DM.

PLoS One. 2017 Nov 27;12(11):e0188288. doi: 10.1371/journal.pone.0188288. eCollection 2017.

10.

MHC-I Genotype Restricts the Oncogenic Mutational Landscape.

Marty R, Kaabinejadian S, Rossell D, Slifker MJ, van de Haar J, Engin HB, de Prisco N, Ideker T, Hildebrand WH, Font-Burgada J, Carter H.

Cell. 2017 Nov 30;171(6):1272-1283.e15. doi: 10.1016/j.cell.2017.09.050. Epub 2017 Oct 26.

11.

Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins.

Daga S, Moyse H, Briggs D, Lowe D, Evans N, Jones J, Buchli R, McMurtrey C, Mulder A, Hildebrand W, Claas F, Higgins R, Mitchell DA, Zehnder D.

Hum Immunol. 2018 Feb;79(2):122-128. doi: 10.1016/j.humimm.2017.10.012. Epub 2017 Oct 31.

PMID:
29097266
12.

Erratum: T cells from patients with Parkinson's disease recognize α-synuclein peptides.

Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Arlehamn CSL, Sette A.

Nature. 2017 Sep 13;549(7671):292. doi: 10.1038/nature23896.

PMID:
28905919
13.

Impact of HLA-DRB1 allele polymorphisms on control of HIV infection in a Peruvian MSM cohort.

Oriol-Tordera B, Llano A, Ganoza C, Cate S, Hildebrand W, Sanchez J, Calle ML, Brander C, Olvera A.

HLA. 2017 Oct;90(4):234-237. doi: 10.1111/tan.13085. Epub 2017 Jul 5.

PMID:
28677168
14.

Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Dulberger CL, McMurtrey CP, Hölzemer A, Neu KE, Liu V, Steinbach AM, Garcia-Beltran WF, Sulak M, Jabri B, Lynch VJ, Altfeld M, Hildebrand WH, Adams EJ.

Immunity. 2017 Jun 20;46(6):1018-1029.e7. doi: 10.1016/j.immuni.2017.06.002.

15.

T cells from patients with Parkinson's disease recognize α-synuclein peptides.

Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Lindestam Arlehamn CS, Sette A.

Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21. Erratum in: Nature. 2017 Sep 13;549(7671):292.

16.

The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands.

Hilton HG, McMurtrey CP, Han AS, Djaoud Z, Guethlein LA, Blokhuis JH, Pugh JL, Goyos A, Horowitz A, Buchli R, Jackson KW, Bardet W, Bushnell DA, Robinson PJ, Mendoza JL, Birnbaum ME, Nielsen M, Garcia KC, Hildebrand WH, Parham P.

Cell Rep. 2017 May 16;19(7):1394-1405. doi: 10.1016/j.celrep.2017.04.059.

17.

Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.

Remesh SG, Andreatta M, Ying G, Kaever T, Nielsen M, McMurtrey C, Hildebrand W, Peters B, Zajonc DM.

J Biol Chem. 2017 Mar 31;292(13):5262-5270. doi: 10.1074/jbc.M117.776542. Epub 2017 Feb 8.

18.

MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates.

Greene JM, Dash P, Roy S, McMurtrey C, Awad W, Reed JS, Hammond KB, Abdulhaqq S, Wu HL, Burwitz BJ, Roth BF, Morrow DW, Ford JC, Xu G, Bae JY, Crank H, Legasse AW, Dang TH, Greenaway HY, Kurniawan M, Gold MC, Harriff MJ, Lewinsohn DA, Park BS, Axthelm MK, Stanton JJ, Hansen SG, Picker LJ, Venturi V, Hildebrand W, Thomas PG, Lewinsohn DM, Adams EJ, Sacha JB.

Mucosal Immunol. 2017 May;10(3):802-813. doi: 10.1038/mi.2016.91. Epub 2016 Oct 19.

19.

A novel canine B-cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics.

Pawlak A, Ziolo E, Kutkowska J, Blazejczyk A, Wietrzyk J, Krupa A, Hildebrand W, Dziegiel P, Dzimira S, Obminska-Mrukowicz B, Strzadala L, Rapak A.

Vet Comp Oncol. 2017 Dec;15(4):1218-1231. doi: 10.1111/vco.12257. Epub 2016 Aug 9.

PMID:
27506920
20.

Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.

Kaabinejadian S, McMurtrey CP, Kim S, Jain R, Bardet W, Schafer FB, Davenport JL, Martin AD, Diamond MS, Weidanz JA, Hansen TH, Hildebrand WH.

J Immunol. 2016 May 15;196(10):4263-73. doi: 10.4049/jimmunol.1501821. Epub 2016 Apr 20.

21.

Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing.

Morozov GI, Zhao H, Mage MG, Boyd LF, Jiang J, Dolan MA, Venna R, Norcross MA, McMurtrey CP, Hildebrand W, Schuck P, Natarajan K, Margulies DH.

Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E1006-15. doi: 10.1073/pnas.1519894113. Epub 2016 Feb 11.

22.

Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove.

McMurtrey C, Trolle T, Sansom T, Remesh SG, Kaever T, Bardet W, Jackson K, McLeod R, Sette A, Nielsen M, Zajonc DM, Blader IJ, Peters B, Hildebrand W.

Elife. 2016 Jan 29;5. pii: e12556. doi: 10.7554/eLife.12556.

23.

The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.

Trolle T, McMurtrey CP, Sidney J, Bardet W, Osborn SC, Kaever T, Sette A, Hildebrand WH, Nielsen M, Peters B.

J Immunol. 2016 Feb 15;196(4):1480-7. doi: 10.4049/jimmunol.1501721. Epub 2016 Jan 18.

24.

Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.

Spencer CT, Bezbradica JS, Ramos MG, Arico CD, Conant SB, Gilchuk P, Gray JJ, Zheng M, Niu X, Hildebrand W, Link AJ, Joyce S.

Proteomics Clin Appl. 2015 Dec;9(11-12):1035-52. doi: 10.1002/prca.201500106.

25.

Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.

Patterson AM, Kaabinejadian S, McMurtrey CP, Bardet W, Jackson KW, Zuna RE, Husain S, Adams GP, MacDonald G, Dillon RL, Ames H, Buchli R, Hawkins OE, Weidanz JA, Hildebrand WH.

Mol Cancer Ther. 2016 Feb;15(2):313-22. doi: 10.1158/1535-7163.MCT-15-0658. Epub 2015 Dec 30.

26.

Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection.

Cram ED, Simmons RS, Palmer AL, Hildebrand WH, Rockey DD, Dolan BP.

Infect Immun. 2015 Nov 23;84(2):480-90. doi: 10.1128/IAI.01254-15. Print 2016 Feb.

27.

Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry.

Abelin JG, Trantham PD, Penny SA, Patterson AM, Ward ST, Hildebrand WH, Cobbold M, Bai DL, Shabanowitz J, Hunt DF.

Nat Protoc. 2015 Sep;10(9):1308-18. doi: 10.1038/nprot.2015.086. Epub 2015 Aug 6.

28.

Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.

Carreno BM, Magrini V, Becker-Hapak M, Kaabinejadian S, Hundal J, Petti AA, Ly A, Lie WR, Hildebrand WH, Mardis ER, Linette GP.

Science. 2015 May 15;348(6236):803-8. doi: 10.1126/science.aaa3828. Epub 2015 Apr 2.

29.

The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression.

Olvera A, Pérez-Álvarez S, Ibarrondo J, Ganoza C, Lama JR, Lucchetti A, Cate S, Hildebrand W, Bernard N, Gomez L, Sanchez J, Brander C.

AIDS. 2015 Mar 13;29(5):507-17. doi: 10.1097/QAD.0000000000000574.

PMID:
25715101
30.

HLA-B*35-PX and HLA-B*35-PY subtype differentiation does not predict observed differences in level of HIV control in a Peruvian MSM cohort.

Olvera A, Ganoza C, Pérez-Álvarez S, Hildebrand W, Sanchez J, Brander C.

AIDS. 2014 Sep 24;28(15):2323-5. doi: 10.1097/QAD.0000000000000403. No abstract available.

PMID:
25313587
31.

Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.

Yaciuk JC, Skaley M, Bardet W, Schafer F, Mojsilovic D, Cate S, Stewart CJ, McMurtrey C, Jackson KW, Buchli R, Olvera A, Cedeño S, Plana M, Mothe B, Brander C, West JT, Hildebrand WH.

J Virol. 2014 Nov;88(22):12992-3004. doi: 10.1128/JVI.01914-14. Epub 2014 Aug 27.

32.

Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes.

Piazza P, Campbell D, Marques E, Hildebrand WH, Buchli R, Mailliard R, Rinaldo CR.

Clin Exp Immunol. 2014 Sep;177(3):696-702. doi: 10.1111/cei.12373.

33.

A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.

Kim S, Pinto AK, Myers NB, Hawkins O, Doll K, Kaabinejadian S, Netland J, Bevan MJ, Weidanz JA, Hildebrand WH, Diamond MS, Hansen TH.

Eur J Immunol. 2014 Jul;44(7):1936-46. doi: 10.1002/eji.201444450. Epub 2014 May 3.

34.

Observation of infinite-range intensity correlations above, at, and below the mobility edges of the 3D Anderson localization transition.

Hildebrand WK, Strybulevych A, Skipetrov SE, van Tiggelen BA, Page JH.

Phys Rev Lett. 2014 Feb 21;112(7):073902. Epub 2014 Feb 19.

PMID:
24579600
35.

Prolonged amelioration of experimental postoperative pain by bupivacaine released from microsphere-coated hernia mesh.

Ohri R, Wang JC, Pham L, Blaskovich PD, Costa D, Nichols G, Hildebrand W, Scarborough N, Herman C, Strichartz GR.

Reg Anesth Pain Med. 2014 Mar-Apr;39(2):97-107. doi: 10.1097/AAP.0000000000000062.

PMID:
24513957
36.

Human herpesvirus 7 U21 tetramerizes to associate with class I major histocompatibility complex molecules.

May NA, Wang Q, Balbo A, Konrad SL, Buchli R, Hildebrand WH, Schuck P, Hudson AW.

J Virol. 2014 Mar;88(6):3298-308. doi: 10.1128/JVI.02639-13. Epub 2014 Jan 3.

37.

Profiling antibodies to class II HLA in transplant patient sera.

McMurtrey C, Lowe D, Buchli R, Daga S, Royer D, Humphrey A, Cate S, Osborn S, Mojsilovic A, VanGundy R, Bardet W, Duty A, Mojsilovic D, Jackson K, Stastny P, Briggs D, Zehnder D, Higgins R, Hildebrand W.

Hum Immunol. 2014 Mar;75(3):261-70. doi: 10.1016/j.humimm.2013.11.015. Epub 2013 Nov 20.

PMID:
24269696
38.

The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategies.

Borchers CH, Kast J, Foster LJ, Siu KW, Overall CM, Binkowski TA, Hildebrand WH, Scherer A, Mansoor M, Keown PA; Human Proteome Organization Chromosome 6 Consortium.

J Proteomics. 2014 Apr 4;100:60-7. doi: 10.1016/j.jprot.2013.08.001. Epub 2013 Aug 8.

39.

Inhibition by local bupivacaine-releasing microspheres of acute postoperative pain from hairy skin incision.

Ohri R, Wang JC, Blaskovich PD, Pham LN, Costa DS, Nichols GA, Hildebrand WP, Scarborough NL, Herman CJ, Strichartz GR.

Anesth Analg. 2013 Sep;117(3):717-30. doi: 10.1213/ANE.0b013e3182a00851. Epub 2013 Aug 6.

PMID:
23921651
40.

Identification of class I HLA T cell control epitopes for West Nile virus.

Kaabinejadian S, Piazza PA, McMurtrey CP, Vernon SR, Cate SJ, Bardet W, Schafer FB, Jackson KW, Campbell DM, Buchli R, Rinaldo CR, Hildebrand WH.

PLoS One. 2013 Jun 10;8(6):e66298. doi: 10.1371/journal.pone.0066298. Print 2013.

41.

Discovering naturally processed antigenic determinants that confer protective T cell immunity.

Gilchuk P, Spencer CT, Conant SB, Hill T, Gray JJ, Niu X, Zheng M, Erickson JJ, Boyd KL, McAfee KJ, Oseroff C, Hadrup SR, Bennink JR, Hildebrand W, Edwards KM, Crowe JE Jr, Williams JV, Buus S, Sette A, Schumacher TN, Link AJ, Joyce S.

J Clin Invest. 2013 May;123(5):1976-87. doi: 10.1172/JCI67388. Epub 2013 Apr 1.

42.

Prolonged nerve block by microencapsulated bupivacaine prevents acute postoperative pain in rats.

Ohri R, Blaskovich P, Wang JC, Pham L, Nichols G, Hildebrand W, Costa D, Scarborough N, Herman C, Strichartz G.

Reg Anesth Pain Med. 2012 Nov-Dec;37(6):607-15. doi: 10.1097/AAP.0b013e3182680f35.

PMID:
22996201
43.

Elevated soluble HLA II protein levels in patients with alpha-1 antitrypsin deficiency with or without COPD.

Li L, Kueppers F, Hildebrand W, Buchli R, Gaughan J.

Exp Lung Res. 2012 Aug;38(6):302-6. doi: 10.3109/01902148.2012.691944. Epub 2012 Jun 11.

PMID:
22686467
44.

Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.

Norcross MA, Luo S, Lu L, Boyne MT, Gomarteli M, Rennels AD, Woodcock J, Margulies DH, McMurtrey C, Vernon S, Hildebrand WH, Buchli R.

AIDS. 2012 Jul 17;26(11):F21-9. doi: 10.1097/QAD.0b013e328355fe8f.

45.

Proteome sampling by the HLA class I antigen processing pathway.

Hoof I, van Baarle D, Hildebrand WH, Keşmir C.

PLoS Comput Biol. 2012;8(5):e1002517. doi: 10.1371/journal.pcbi.1002517. Epub 2012 May 17.

46.

A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules.

Sette A, Sidney J, Southwood S, Moore C, Berry J, Dow C, Bradley K, Hoof I, Lewis MG, Hildebrand WH, McMurtrey CP, Wilson NA, Watkins DI, Mothé BR.

Immunogenetics. 2012 Jun;64(6):421-34. doi: 10.1007/s00251-011-0598-5. Epub 2012 Feb 10.

47.

Definition of the viral targets of protective HIV-1-specific T cell responses.

Mothe B, Llano A, Ibarrondo J, Daniels M, Miranda C, Zamarreño J, Bach V, Zuniga R, Pérez-Álvarez S, Berger CT, Puertas MC, Martinez-Picado J, Rolland M, Farfan M, Szinger JJ, Hildebrand WH, Yang OO, Sanchez-Merino V, Brumme CJ, Brumme ZL, Heckerman D, Allen TM, Mullins JI, Gómez G, Goulder PJ, Walker BD, Gatell JM, Clotet B, Korber BT, Sanchez J, Brander C.

J Transl Med. 2011 Dec 7;9:208. doi: 10.1186/1479-5876-9-208.

48.

TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells.

Weidanz JA, Hawkins O, Verma B, Hildebrand WH.

Int Rev Immunol. 2011 Oct-Dec;30(5-6):328-40. doi: 10.3109/08830185.2011.604880. Review.

49.

Expanding the targets available to therapeutic antibodies via novel disease-specific markers.

Weidanz JA, Hildebrand WH.

Int Rev Immunol. 2011 Oct-Dec;30(5-6):312-27. doi: 10.3109/08830185.2011.608136. Review.

50.

A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.

Buranapraditkun S, Hempel U, Pitakpolrat P, Allgaier RL, Thantivorasit P, Lorenzen SI, Sirivichayakul S, Hildebrand WH, Altfeld M, Brander C, Walker BD, Phanuphak P, Hansasuta P, Rowland-Jones SL, Allen TM, Ruxrungtham K.

PLoS One. 2011;6(8):e23603. doi: 10.1371/journal.pone.0023603. Epub 2011 Aug 22.

Supplemental Content

Loading ...
Support Center